RECENT NEWS
Revvity launches first scientific SaaS platform to drive innovation
Revvity has announced the launch of its Signals Research Suite, a unified, cloud-native software-as-a-service (SaaS) platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.
Roche awarded WHO prequalification for cobas HPV test
Roche has announced that the HPV test for use on the cobas 6800/8800 systems has been awarded World Health Organization (WHO) prequalification. WHO prequalification expands the availability of this critical HPV screening tool in countries that rely on the global organisation’s list in making purchasing and implementation decisions.
Axol Bioscience collaborates with StrataStem to support Alzheimer’s disease drug development
Axol Bioscience, a leading pluripotent stem cell technology provider for drug discovery, has signed an exclusive agreement with StrataStem to access and commercialise its extensive collection of Alzheimer’s disease (AD) patient samples.
Thermo Fisher Scientific launches ground-breaking Orbitrap Astral mass spectrometer
Thermo Fisher Scientific has launched its new Thermo Scientific Orbitrap Astral mass spectrometer, which it says is one of the most significant advancements in mass spectrometry in 15 years. The new Astral analyser combines fast throughput, high sensitivity and deep proteome coverage to allow researchers worldwide to uncover proteins that previously evaded detection and make breakthrough discoveries more efficiently than ever.
SHOT to host patient identification webinars
Serious Hazards of Transfusion (SHOT) has announced details of two new webinars to focus on patient identification for safe transfusion.
Drug Discovery 2023 announces keynote speakers
The European Laboratory Research & Innovation Group (ELRIG) UK has announced the keynote speakers for Drug Discovery 2023, taking place at the ACC in Liverpool on 18–19 October. Professor Janet Hemingway CBE, FRS, Founding Director of Infection Innovation Consortium (iiCON), and Dr Dave Powell, Chief Scientific Officer (CSO) of LifeArc will lead this year’s event focusing on diverse thinking and new perspectives.
Multi-cancer blood test shows real promise in NHS trial
An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.
Beckman Coulter Life Sciences launches first Microbioreactor Light Array Module
Beckman Coulter Life Science has boosted the field of microbioreactor research with the launch of its powerful new Light Array Module (LAM) for the popular BioLector XT Microbioreactor. This new advancement now enables work with light-dependent organisms that need to perform photosynthesis to grow.
Paige introduces AI-based biomarker for colon cancer diagnosis
Digital pathology and clinical AI firm Paige has announced a new AI-based digital assay to support pathologists in the detection and diagnosis of microsatellite instability (MSI) status in colon cancers.
Nucleai to collaborate with Mayo Clinic BioPharma Diagnostics on drug development
Nucleai, a leading provider of artificial intelligence (AI) solutions for pathology and spatial biology, and Mayo Clinic BioPharma Diagnostics have announced a strategic collaboration to bring world-class digital pathology solutions, technologies, and services to support drug development and clinical practice.
Gene-editing tool could help reduce spread of antimicrobial resistance
A new tool which could help reduce the spread of antimicrobial resistance is showing early promise, through exploiting a bacterial immune system as a gene editing tool, according to new research.
Revvity’s EUROIMMUN launches automated IIFT system
Revvity has announced today that its EUROIMMUN business has launched the UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. Now available in countries accepting the CE mark, this all-in-one solution increases the efficiency of the entire IIFT process, encompassing sample preparation, incubation, washing and mounting of slides as well as image acquisition and analysis.
CardioRenal receives FDA Breakthrough Device Designation for TENOR
CardioRenal, a pioneer in the remote treatment of patients with severe chronic kidney disease (CKD), has announced that its TENOR device has obtained Breakthrough Device Designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA).
Cellular Origins launches Constellation automated cell therapy platform
Cellular Origins has launched Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy (ISCT) Annual Meeting 2023. Designed to automate the manufacturing of advanced therapies without significant process redevelopment, Constellation combines aseptic fluid handling technologies with advanced automation.
Avacta acquires Coris Bioconcept
Avacta, a life sciences company developing targeted oncology drugs and diagnostics, has acquired Belgian firm Coris Bioconcept which develops, manufactures and markets rapid diagnostic test kits.
Blood biomarker can help predict Alzheimer’s - study
New research has revealed further details of how Alzheimer’s disease is caused, and a blood test could predict who will go on to develop the condition. A new paper published in Nature Medicine by staff at the University of Pittsburgh School of Medicine found that the build-up of amyloid protein in the brain, long associated with the disease, may in itself not be enough to cause symptoms.
MHRA announces new routes for medicine approval via international partners
New regulatory recognition routes for medicines will be established using approvals from Australia, Canada, the European Union, Japan, Switzerland, Singapore and the United States, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced.
PathPresenter passes 50,000 global users
PathPresenter, the global image sharing platform for pathology, has announced that its free public platform now has more than 50,000 registered users in 172 countries. Nearly 7,000 users have joined the pathology image sharing community in the past 12 months.
IBMS publishes 2022 Annual Report
The Institute of Biomedical Science (IBMS) has published its 2022 Annual Report, reflecting on the support it is providing its members and how it is using its channels to raise awareness of biomedical science.
Validair Monitoring Solutions rebrands as FMS
Validair Monitoring Solutions has chosen to rebrand its business and has changed its name to FMS. The move comes as the company expands into new sectors with facility-wide and cleanroom airborne particle monitoring increasingly relevant in markets beyond the pharmaceutical industry.
Featured Supplier
Pro-Lab Diagnostics – a leading manufacturer and supplier of an extensive range of high quality in vitro diagnostics kits and reagents. The current range includes The Prolisa™ EIA range of kits including C.Diff GDH, Cryptosporidium, Giardia and EHEC, The Prolex™ range of latex kits including MRSA, Staph, Strep, Legionella and E.coli 0157, Vision...
Upcoming Events
BIVDA Annual Regulatory Affairs Seminar
The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023
Drug Discovery 2023
ACC Exhibition Centre, Liverpool
18-19 October
MEEGID XVI
Hilton Dresden, Germany
14-17 November 2023
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
